These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26680586)

  • 61. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.
    Clark SD; Duangdao DM; Schulz S; Zhang L; Liu X; Xu YL; Reinscheid RK
    J Comp Neurol; 2011 Jul; 519(10):1867-93. PubMed ID: 21452235
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.
    Ionescu IA; Dine J; Yen YC; Buell DR; Herrmann L; Holsboer F; Eder M; Landgraf R; Schmidt U
    Neuropsychopharmacology; 2012 May; 37(6):1323-37. PubMed ID: 22278093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuropeptide S promotes maintenance of newly formed dendritic spines and performance improvement after motor learning in mice.
    Li C; Wu XJ; Li W
    Peptides; 2022 Oct; 156():170860. PubMed ID: 35970276
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.
    Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G
    Peptides; 2013 Jan; 39():16-20. PubMed ID: 23142110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Behavioral phenotyping of neuropeptide S receptor knockout mice.
    Duangdao DM; Clark SD; Okamura N; Reinscheid RK
    Behav Brain Res; 2009 Dec; 205(1):1-9. PubMed ID: 19646487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.
    Domschke K; Reif A; Weber H; Richter J; Hohoff C; Ohrmann P; Pedersen A; Bauer J; Suslow T; Kugel H; Heindel W; Baumann C; Klauke B; Jacob C; Maier W; Fritze J; Bandelow B; Krakowitzky P; Rothermundt M; Erhardt A; Binder EB; Holsboer F; Gerlach AL; Kircher T; Lang T; Alpers GW; Ströhle A; Fehm L; Gloster AT; Wittchen HU; Arolt V; Pauli P; Hamm A; Deckert J
    Mol Psychiatry; 2011 Sep; 16(9):938-48. PubMed ID: 20603625
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Caffeine treatment regulates neuropeptide S system expression in the rat brain.
    Lage R; Diéguez C; López M
    Neurosci Lett; 2006 Dec; 410(1):47-51. PubMed ID: 17055161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A single-nucleotide polymorphism of human neuropeptide s gene originated from Europe shows decreased bioactivity.
    Deng C; He X; Hsueh AJ
    PLoS One; 2013; 8(12):e83009. PubMed ID: 24386135
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuropeptide S inhibits gastrointestinal motility and increases mucosal permeability through nitric oxide.
    Wan Saudi WS; Halim MA; Rudholm-Feldreich T; Gillberg L; Rosenqvist E; Tengholm A; Sundbom M; Karlbom U; Näslund E; Webb DL; Sjöblom M; Hellström PM
    Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(8):G625-34. PubMed ID: 26206857
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of the Neuropeptide S System in Emotionality, Stress Responsiveness and Addiction-Like Behaviours in Rodents: Relevance to Stress-Related Disorders.
    Tobinski AM; Rappeneau V
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451877
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuropeptide S produces antinociceptive effects at the supraspinal level in mice.
    Li W; Chang M; Peng YL; Gao YH; Zhang JN; Han RW; Wang R
    Regul Pept; 2009 Aug; 156(1-3):90-5. PubMed ID: 19345242
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of central neuropeptide S in the mouse formalin test.
    Peng YL; Zhang JN; Chang M; Li W; Han RW; Wang R
    Peptides; 2010 Oct; 31(10):1878-83. PubMed ID: 20603169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S.
    Fedeli A; Braconi S; Economidou D; Cannella N; Kallupi M; Guerrini R; Calò G; Cifani C; Massi M; Ciccocioppo R
    Eur J Neurosci; 2009 Oct; 30(8):1594-602. PubMed ID: 19821837
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin.
    Wigger A; Sánchez MM; Mathys KC; Ebner K; Frank E; Liu D; Kresse A; Neumann ID; Holsboer F; Plotsky PM; Landgraf R
    Neuropsychopharmacology; 2004 Jan; 29(1):1-14. PubMed ID: 12942143
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
    Tancredi T; Guerrini R; Marzola E; Trapella C; Calo G; Regoli D; Reinscheid RK; Camarda V; Salvadori S; Temussi PA
    J Med Chem; 2007 Sep; 50(18):4501-8. PubMed ID: 17696420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods.
    Reinscheid RK
    Peptides; 2007 Apr; 28(4):830-7. PubMed ID: 17293003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.
    Lennertz L; Franke PE; Grabe HJ; Rampacher F; Schulze-Rauschenbach S; Guttenthaler V; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Wagner M; Mössner R
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1951-8. PubMed ID: 23680103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain neuropeptide S: via GPCR activation to a powerful neuromodulator of socio-emotional behaviors.
    Grund T; Neumann ID
    Cell Tissue Res; 2019 Jan; 375(1):123-132. PubMed ID: 30112573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.
    Clark SD; Kenakin TP; Gertz S; Hassler C; Gay EA; Langston TL; Reinscheid RK; Runyon SP
    Neuropharmacology; 2017 May; 118():69-78. PubMed ID: 28267583
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation.
    Domschke K; Klauke B; Winter B; Gajewska A; Herrmann MJ; Warrings B; Mühlberger A; Wosnitza K; Dlugos A; Naunin S; Nienhaus K; Fobker M; Jacob C; Arolt V; Pauli P; Reif A; Zwanzger P; Deckert J
    Psychopharmacology (Berl); 2012 Aug; 222(3):533-41. PubMed ID: 22399050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.